Topical Expertise MedPharm-US specializes in topical and transdermal formulations and performance testing with a strong patent portfolio, indicating opportunities to license or co-develop proprietary delivery systems for skin, nail, mucous membranes, eye, nose and lung applications.

Strategic Partnerships The company commercializes MedSpray, MedRo, MedTherm and AquaRMed technologies with partners and seeks third‑party licensing, suggesting a clear path for collaboration, licensing deals, or white‑label partnerships with firms seeking advanced delivery platforms.

Tailored Solutions Internal development pipeline and disease-relevant biological models imply potential B2B opportunities for contract development and testing services, as well as joint ventures to expand the portfolio into additional topical indications.

Growth Readiness Revenue in the lower mid‑range and a focus on niche, specialized formulations position MedPharm-US as a scalable partner for mid‑sized pharma or biotech players needing expert formulation testing and regulatory‑ready delivery systems.

Competitive Positioning As a US subsidiary of a leading specialist clinic for topical delivery, MedPharm‑US can leverage its parent’s brand and patent assets to target collaborations with larger dermatology and ophthalmology players seeking differentiated transdermal technologies.